NYSE:GMED Globus Medical (GMED) Stock Price, News & Analysis $76.23 -2.06 (-2.63%) As of 11:02 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Globus Medical Stock (NYSE:GMED) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Globus Medical alerts:Sign Up Key Stats Today's Range$76.24▼$78.2950-Day Range$75.48▼$88.4852-Week Range$54.15▼$101.40Volume199,457 shsAverage Volume1.45 million shsMarket Capitalization$10.23 billionP/E Ratio19.49Dividend YieldN/APrice Target$101.77Consensus RatingModerate Buy Company Overview Globus Medical, Inc. (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes. In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room. The ExcelsiusGPS® robotic guidance system, for example, integrates real-time imaging with robotic arm technology to enable surgeons to perform complex procedures with greater accuracy. The company also offers an array of trauma and orthopaedic solutions, such as bone graft substitutes and joint reconstruction implants, to address a broad spectrum of musculoskeletal conditions. Globus Medical serves surgeons and patients across North America, Europe, Asia, Latin America and the Middle East through a combination of direct sales and distribution partnerships. Under the leadership of founder and Executive Chairman David C. Paul and President and Chief Executive Officer Glenn J. Shapiro, the company has built a global commercial infrastructure and invested in research and development to drive innovation. Its commitment to surgical education and customer support further reinforces its position in the competitive medical device landscape.AI Generated. May Contain Errors. Read More Globus Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks91st Percentile Overall ScoreGMED MarketRank™: Globus Medical scored higher than 91% of companies evaluated by MarketBeat, and ranked 41st out of 906 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingGlobus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 3 strong buy ratings, 9 buy ratings, 5 hold ratings, and no sell ratings.Upside PotentialGlobus Medical has a consensus price target of $101.77, representing about 30.0% upside from its current price of $78.27.Amount of Analyst CoverageGlobus Medical has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Globus Medical's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.02% Earnings GrowthEarnings for Globus Medical are expected to grow by 8.02% in the coming year, from $4.99 to $5.39 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Globus Medical is 20.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.27.Price to Earnings Ratio vs. SectorThe P/E ratio of Globus Medical is 20.02, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.28.Price to Earnings Growth RatioGlobus Medical has a PEG Ratio of 1.26. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGlobus Medical has a P/B Ratio of 2.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Globus Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.21% of the float of Globus Medical has been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 3.95, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Globus Medical has recently decreased by 1.22%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGlobus Medical does not currently pay a dividend.Dividend GrowthGlobus Medical does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.85 News SentimentGlobus Medical has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Globus Medical this week, compared to 6 articles on an average week.Search InterestOnly 11 people have searched for GMED on MarketBeat in the last 30 days. This is a decrease of -8% compared to the previous 30 days.MarketBeat Follows6 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Globus Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,176,000.00 in company stock.Percentage Held by Insiders18.38% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Globus Medical's insider trading history. Receive GMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GMED Stock News HeadlinesGlobus Medical (NYSE:GMED) vs. TELA Bio (NASDAQ:TELA) Head-To-Head ComparisonSeptember 8 at 4:47 AM | americanbankingnews.comGlobus Medical (GMED) Received CE Mark For Its Excelsius3D Imaging SystemSeptember 4, 2026 | finance.yahoo.comFeds Say Your Cash Isn’t Property—Can They Take It?The Department of Justice recently argued in court that cash may not qualify as legal property. That raises new questions about how protected everyday bank accounts and retirement savings really are.September 8 at 1:00 AM | Priority Gold (Ad)Globus Medical granted CE mark for mobile X-ray system in EuropeSeptember 4, 2026 | seekingalpha.comGlobus Medical Secures CE Mark For Excelsius3D Imaging System In EuropeSeptember 4, 2026 | rttnews.comGlobus Medical, Inc. (NYSE:GMED) Given Consensus Recommendation of "Moderate Buy" by AnalystsSeptember 4, 2026 | americanbankingnews.comGlobus Medical Slides 3.1% Despite New Product Milestone as Investors Weigh Recent Growth QuestionsSeptember 3, 2026 | quiverquant.comQInsider Selling: Globus Medical (NYSE:GMED) Director Sells 25,000 Shares of StockAugust 20, 2026 | insidertrades.comSee More Headlines GMED Stock Analysis - Frequently Asked Questions How have GMED shares performed this year? Globus Medical's stock was trading at $87.39 at the beginning of the year. Since then, GMED shares have decreased by 10.4% and is now trading at $78.27. How were Globus Medical's earnings last quarter? Globus Medical, Inc. (NYSE:GMED) released its quarterly earnings results on Thursday, August, 6th. The medical device company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.24. The business's quarterly revenue was up 5.9% compared to the same quarter last year. Read the conference call transcript. Is Globus Medical buying back stock? Globus Medical's board authorized a stock repurchase program on Thursday, May 15th 2025, which allows the company to repurchase $500,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 6.3% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's board believes its stock is undervalued. When did Globus Medical IPO? Globus Medical (GMED) raised $200 million in an initial public offering on Friday, August 3rd 2012. The company issued 11,764,705 shares at $16.00-$18.00 per share. Who are Globus Medical's major shareholders? Top institutional shareholders of Globus Medical include California State Teachers Retirement System (7.69%), Paradigm Capital Management Inc. NY (0.65%), American Capital Management Inc. (0.49%) and Annex Advisory Services LLC (0.27%). Insiders that own company stock include David D Davidar, Stephen T Zarrilli, Ann D Rhoads, Leslie V Norwalk, Dan Lemaitre, Daniel T Scavilla, Keith W Pfeil, Kelly Huller and Kyle Kline. View institutional ownership trends. How do I buy shares of Globus Medical? Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Globus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET), Advanced Micro Devices (AMD) and ServiceNow (NOW). Company Calendar Last Earnings8/06/2026Today9/08/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 2 weeks, GMED's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:GMED CIK1237831 Webwww.globusmedical.com Phone(610) 930-1800Fax610-930-2042Employees6,000Year Founded2003Price Target and Rating Average Price Target for Globus Medical$101.77 High Price Target$123.00 Low Price Target$80.00 Potential Upside/Downside+32.9%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage17 Analysts Profitability EPS (Trailing Twelve Months)$3.91 Trailing P/E Ratio19.68 Forward P/E Ratio15.35 P/E Growth1.26Net Income$537.87 million Net Margins17.02% Pretax Margin20.99% Return on Equity14.57% Return on Assets12.62% Debt Debt-to-Equity RatioN/A Current Ratio4.62 Quick Ratio2.93 Sales & Book Value Annual Sales$2.94 billion Price / Sales3.50 Cash Flow$6.15 per share Price / Cash Flow12.46 Book Value$33.86 per share Price / Book2.26Miscellaneous Outstanding Shares134,260,000Free Float109,585,000Market Cap$10.28 billion OptionableOptionable Beta0.95 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:GMED) was last updated on 9/8/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | SponsoredBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...Monument Traders Alliance | SponsoredThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...Behind the Markets | SponsoredForget SpaceX, Elon Is Now Powering the Next Hot IPOElon Musk is backing a new AI startup that's quietly growing faster than Tesla, SpaceX, and reportedly 23 time...Brownstone Research | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredWhat Is A Roth Conversion, And How Do I Set One Up?A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...SmartAsset | SponsoredThis looks like plywood. It's not.AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
